On January 10, 2020, the U.S. Patent and Trademark Office Patent Trial and Appeal Board affirmed the Examiner’s decision in the Ex Parte Reexamination of U.S. Patent No. 9,313,456. Attorneys at Weide & Miller submitted the [...]
2019 was an extremely successful year, with Weide & Miller obtaining the issuance of 101 U.S. utility and design patents for its clients.
Weide & Miller obtains a complete reversal at the Patent Trial and Appeal Board. Weide & Miller had appealed the examiner’s rejection of all claims in U.S. Application Serial No. 15/057,289, directed to a closed-loop medication monitoring [...]
On March 4, 2019, the Supreme Court resolved an issue on which the various federal circuit courts were split: can a copyright plaintiff bring a lawsuit once they have filed an application for registration with the Copyright [...]
UNDERSTANDING 35 U.S.C. § 101 AND THE ALICE DECISION Overview Section 101 sets forth the type of inventions which are entitled to be patented (assuming they meet the other requirements for patentability, such as novelty (under Section [...]
In the case of Helsinn Healthcare S.A., v. Teva Pharmaceuticals USA, Inc., et al., the U.S. Supreme Court ruled that changes to Section 102 of the America Invents Act did not change the meaning of the “on-sale” [...]
The USPTO has issued modified subject-matter eligibility (“Section 101”) guidance. The new guidance recognizes the need for increased clarity and consistency in how Section 101 is applied. Under current Section 101 case law, an invention may [...]
Weide & Miller issued 88 patents in 2018, leading Nevada based firms.
In the case of Arista Networks, Inc. v. Cisco Sys., Inc. (Federal Circuit, November 9, 2018), the Court of Appeals for the Federal Circuit addressed the issue of whether assignee estoppel applies to prevent an inventor/assignor from [...]
Weide & Miller issued 34 patents in the first half of 2018.